{
  "variant_id": {
    "Gene": "EGFR",
    "Protein_Change": {
      "ref": "A",
      "alt": "T",
      "position": "290"
    },
    "variant_string_id": "EGFR A290T"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "EGFR mutations are known to cause constitutive activation of the receptor, leading to uncontrolled cell growth and lung cancer.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism (uncontrolled cell growth due to EGFR mutation) and how EGFR functions within it."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Cell viability assays were used to assess the impact of EGFR mutations on tumor cell growth.",
      "judgment": "Yes",
      "reasoning": "Cell viability assays effectively model the disease mechanism (tumor cell growth) and are a well-established method in oncology research.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "No wild-type or known pathogenic EGFR variants were used as controls in the assay.",
      "judgment": "No",
      "reasoning": "Basic controls (wild-type or known pathogenic variants) were not included, so this step is insufficient."
    },
    {
      "step_name": "Sub-step 3b: Accepted/Validated Assay",
      "extracted_paper_info": "Cell viability assays are a standard technique in oncology research.",
      "judgment": "Yes",
      "reasoning": "The assay is broadly accepted in the field, even though basic controls were not used."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "No statistical analyses were performed for the EGFR A290T assay.",
      "judgment": "No",
      "reasoning": "There is no mention of statistical tests, p-values, or effect sizes."
    },
    {
      "step_name": "Sub-step 4b: No OddsPath Calculation",
      "extracted_paper_info": "No explicit controls (benign or pathogenic variants) were used in the assay.",
      "judgment": "Total controls = 0 (less than 11)",
      "reasoning": "Since fewer than 11 control variants were used, the functional evidence strength is limited."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The EGFR A290T variant demonstrates moderate functional evidence supporting its potential pathogenicity, as the assay used a broadly accepted method but lacked basic controls and statistical analysis."
}